Le Lézard
Classified in: Health, Science and technology

Announcing Director of White House Office of National Drug Control Policy as Guest Speaker at Faces & Voices of Recovery's Recovery Leadership Summit


Dr. Gupta joins Johann Hari, Chacku Mathai, and Maia Szalavitz as speakers at this year's conference.

ST. PAUL, Minn., Oct. 1, 2022 /PRNewswire-PRWeb/ -- Faces & Voices of Recovery is pleased to announce Dr. Rahul Gupta as a guest speaker at the annual Recovery Leadership Summit, held this year in St. Paul, MN from October 2-5.

Rahul Gupta, MD, MPH, MBA, FACP, is the first medical doctor to serve as the Director of National Drug Control Policy and lead the Office of National Drug Control Policy (ONDCP), a component of the Executive Office of the President.

Dr. Gupta is a national and global thought leader and a driver of innovative public policies who practices what he preaches. He is a buprenorphine-waivered practitioner, providing medication-assisted treatment for people with opioid use disorder.

"Faces & Voices is honored to call Dr. Gupta an ally, advocate, and friend of the recovery movement. When leaders speak up to end stigma and fight for change, it benefits all communities, families, and people," says Phil Rutherford, Chief Operating Officer of Faces & Voices of Recovery.

The 2022 Recovery Leadership Summit will be held at RiverCentre on October 2-5. This annual conference of Recovery Leaders and Advocates is hosted by Faces & Voices of Recovery, the nation's leading recovery advocacy organization since 2001.

Donations to support Faces & Voices and the recovery community can be made online at https://facesandvoicesofrecovery.org/get-involved/donate/online-giving/. Charitable contributions support Faces & Voices of Recovery's efforts to eliminate the stigma of substance use disorders and make recovery possible for even more people.

Faces & Voices of Recovery is dedicated to organizing and mobilizing the over 23 million Americans in recovery from addiction to alcohol and other drugs. With the support of families, friends, and allies, recovery community organizations and networks are able to promote the right and resources to recover through advocacy, education, and demonstrating the power and proof of long-term recovery. For more information, visit http://www.facesandvoicesofrecovery.org.

Contact
Emily Porcelli
Marketing & Communications Manager
Faces & Voices of Recovery
202-737-0690
[email protected]

Media Contact

Emily Porcelli, Faces & Voices of Recovery, 1 202.741.9430, [email protected]

Patty McCarthy, Faces & Voices of Recovery, 2027370692, [email protected]

Facebook

 

SOURCE Faces & Voices of Recovery


These press releases may also interest you

at 20:50
AmerisourceBergen Corporation today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $200 million in concurrence with Walgreens Boots Alliance's sale of...

at 20:00
Shaw Industries Group Inc. (Shaw) today announced it has enrolled to pursue the new WELL Equity Rating developed by the International WELL Building Institute (IWBI). The WELL Equity Rating is designed to help organizations act on their diversity,...

at 19:11
Alameda Health System (AHS) received the 2022 Quality Leader Awards (QLA) Top Honor for the BElovedBIRTH Black Centering program, which is administered in partnership with the Alameda County Health Care Services Agency's Public Health Department...

at 19:05
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the first immunological results of its PDC-LUNG-101 phase I/II clinical trial (NCT03970746) with...

at 19:00
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major...

at 19:00
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major...



News published on 1 october 2022 at 10:35 and distributed by: